Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 103,795 | reported | 31 Dec 2025 | tx 30+768,416−32,643 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 7,858 | 0.58 USD | |
| 30 Sept 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,420 | 0.34 USD | |
| 30 Jun 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,420 | 1.65 USD | |
| 31 Mar 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 8,399 | 1.58 USD | |
| 21 Jan 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 230,000 | 0.00 USD | deriv |
| 31 Dec 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 4,675 | 3.35 USD | |
| 30 Sept 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 84 | 1.88 USD | |
| 01 Jul 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 92 | 1.92 USD | |
| 01 Apr 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 94 | 3.08 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 93 | 2.28 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 02 Oct 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,087 | 3.83 USD | |
| 30 Jun 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 91 | 4.10 USD | |
| 31 Mar 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 384 | 3.08 USD | |
| 31 Dec 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 354 | 0.15 USD | |
| 30 Sept 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 353 | 0.22 USD | |
| 30 Jun 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 354 | 0.39 USD | |
| 31 May 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 12,510 | 0.35 USD | |
| 31 Mar 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 773 | 0.65 USD | |
| 17 Mar 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 75,000 | 0.00 USD | |
| 17 Mar 2022 | GRANT_AWARD | VYNE Therapeutics Inc. | 75,000 | 0.00 USD | deriv |
| 31 Dec 2021 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 206 | 1.02 USD |